PORTLAND, Ore.— Conception Nurseries, a cannabis micropropagation company that has been quietly developing cannabis tissue culture clones for nearly two years, is now launching publicly. Conception is bringing tissue culture technology, a crucial component of industrial scale agriculture, to the cannabis industry. With tissue culture micropropagation, Conception produces plantlets that are free of pathogens and have exceptional vigor, at a cost-per-plant below producers’ in-house costs.
Conception is led by Chief Executive Officer Kevin Brooks. Kevin most recently served as the CEO of Connected Cannabis, the largest vertically integrated cannabis company in California. Before entering the cannabis industry, Kevin spent 15 years as an executive in Silicon Valley supporting companies through multiple successful exits.
In partnership with both Phylos, the leading cannabis agricultural genomics company, and CropOne, the largest and highest yielding vertical agriculture company, Conception provides cultivators with next-generation, targeted cannabis varieties customized for the needs of consumers and cultivators.
Through its partnership with Phylos, Conception’s tissue culture clones will each be genetically tested and registered with Phylos. A unique genetic ID is assigned to each plant tested, and includes a report revealing identical clone matches and how they’re related to varieties around the world.
Through its technology partnership with CropOne, Conception will use the world’s leading controlled-environment agriculture platform and plantlet development technology to ensure plantlets are pathogen free as well as consistent, vigorous growers.
Conception will be launching its Series A funding and facility rollout plans.
Conception is bringing tissue culture technology, a crucial component of industrial scale agriculture, to the cannabis industry. With tissue culture “micropropagation,” Conception produces plantlets that are free of pathogens and have exceptional vigor, at a cost-per-plant below producers’ in-house costs. Conception is a partnership between Phylos and CropOne.
Phylos is the world’s leading provider of cannabis genomics. Using modern molecular genetics and computational biology, Phylos is driving the development and improvement of hemp and drug varieties for optimal performance across diverse agricultural environments. Our world-class team supports research and development, breeding partnerships with global partners, and cultivation businesses worldwide with a comprehensive suite of genetic testing solutions.
Crop One Holdings (COH) is the world’s largest vertical farmer. Using advanced, soilless hydroponic technology and proprietary plant science, COH brings fresh, clean produce closer to the consumer. COH grows in a digitally-controlled modular environment, enabling year-round production without pesticides. This process is reinforced by USDA GAP & GHP certifications, minimizing contamination. In commercial production longer than any other major U.S. vertical farmer, COH is the holding company for FreshBox Farms in Massachusetts and a JV with Emirates Flight Catering in Dubai.